Refine by
Oncology Articles & Analysis: Older
123 articles found
By specializing in diverse drug development services and therapeutic methodologies, Alfa Cytology is poised to make significant contributions to the field of oncology and continues to expand its capabilities in response to the evolving demands of cancer research.Learn more: cancer vaccine development services ...
In conclusion, the synergistic relationship between tumor models for breast cancer and customized ADCs development services is setting a new standard in oncology research. By fostering a deeper understanding of tumor biology and enabling targeted therapeutic strategies, these innovations hold the potential to significantly improve outcomes for breast cancer patients. ...
This process also aids in screening for monoclonal antibodies with high specificity and affinity, crucial for therapeutic applications in oncology, infectious diseases, and autoimmune disorders. 4. Glycan-Based Drug Discovery The study of glycan structures has led to the discovery of novel drug candidates targeting glycan-related pathways. ...
The development of miRNA-based therapies has garnered significant interest, with some products currently in clinical trials. Beyond oncology, miRNA mimics have potential applications in treating various conditions, including cardiovascular diseases, metabolic disorders, and neurodegenerative diseases. ...
Brain tumors represent a significant oncology challenge due to their complex genetic profiles and diverse clinical manifestations. ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. However, the success and general applicability of these treatments heavily depend on the diversity of the participants involved¹?³. This blog explores the importance of achieving data diversity in clinical trials to enhance clinical trial results and ...
Discover how matched tumor-normal sequencing can help clinical researchers detect the somatic origin of variants with certainty. In the era of precision oncology, it has become increasingly common for patients diagnosed with cancer to undergo tumor sequencing. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to advance personalized cancer treatment strategies. ...
Here, we provide global customers professional technical support with experienced scientists and advanced technology in centrosome research and related fields, including oncology, immunology, neurology, cell biology, cellular dynamics, and many other areas. ...
Overall, the integration of multi-omics data and advancements in immune-oncology plays a significant part in developing precise treatments for brain tumors2. ...
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. ...
In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...
PEG derivatives play a crucial role in developing such systems, particularly in oncology. For instance, PEGylated liposomes and nanoparticles can be engineered to carry anticancer drugs directly to tumor sites. ...
We recently spoke with Manuela Badiali, Rita Congiu, and Stefania Murru from the Laboratory of Genetics and Genomics, Microcitemico Pediatric Hospital – A. Cao, Cagliari, about how SOPHiA DDM™ RNAtarget Technology has helped them optimize their variant analysis workflow. ...
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. Alfa Cytology, a biotech company composed of scientists, bioinformatics, and oncologists, has recently announced its pancreatic cancer vaccine development services to provide further strategies for cancer therapy research. Compared to other solid tumors, ...
Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for precision medicine. ...
ByTempus
Oncology drug development makes up almost half of the annual R&D expenditure of biopharmaceutical companies. ...
This white paper details a study by Predictive Oncology and UPMC Magee-Womens Hospital. By combining the assets and domain expertise of both organizations, this collaboration aimed to improve ovarian cancer prognosis and treatment through accurate patient stratification and survival outcome predictions. ...
The team of Alfa Cytology brings together expertise in oncology, molecular biology, drug development, etc. With a deep understanding of the challenges and nuances of cancer research, Alfa Cytology provides innovative solutions and insights. ...